全新好(000007.SZ):全資子公司與晨採實業簽訂產品銷售合作合同
格隆匯4月21日丨全新好(000007.SZ)公佈,為進一步落實向生活用紙領域的造紙商經銷商提供技術及產品的工作,加快落實向生活用紙領域的造紙商和經銷商提供技術和產品的工作,開拓市場業務,公司全資子公司零度大健康技術(深圳)有限公司(“零度大健康”,合同稱“甲方”)於2020年4月20日與江門市晨採實業有限公司(“晨採實業”,合同稱“乙方”)簽訂了《產品銷售合作合同》。
業績目標:1、甲方授權乙方成為平台業務代理商後12月內,乙方應促使拓展的品牌商完成消毒殺菌紙銷售規模合計不低於原紙15000噸;乙方應促使單一品牌商銷售規模不低於原紙2000噸。
2、甲方有權以半年度為單位,考核代理商、品牌商業績指標,對於未達到業績指標的代理商、品牌商,有權依照相應標準,終止合作關係。
3、協議簽訂後,乙方應當於60天內,完成品牌商的篩選、簽約、產品生產及檢測合格並完成首批殺菌紙產品正式推向市場。
納米膠囊現行標準價格為每噸殺菌紙不低於2000元(因eleten研究所與上海東冠紙業有價位承諾)。
晨採實業為紙巾行業運營管理企業,具有一定的渠道資源及運營經驗。零度大健康與晨採實業《產品銷售合作合同》的簽訂,進一步明確了合作目標、合作的安排及方案實施,有利於後續銷售業務有序開展。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.